Pancreatic cancer from bench to bedside: molecular pathways and treatment options

In the last forty years the pancreatic cancer treatment has made advances, however; still novel drugs are needed. It is known that the five year survival rate remains around 5%. The best treatment option still remains surgery, if patients are diagnosed early. In the last decade the biology of pancre...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ann Transl Med
Glavni autori: Kosmidis, Christoforos, Sapalidis, Konstantinos, Kotidis, Efstathios, Mixalopoulos, Nikolaos, Zarogoulidis, Paul, Tsavlis, Drosos, Baka, Sofia, Man, Yan-Gao, Kanellos, John
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2016
Teme:
Focus on Surgical Techniques from Bench to Bedside
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4876273/
https://ncbi.nlm.nih.gov/pubmed/27275478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.05.11
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items